Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based Study

30 Although a higher hazard of hematologic findings was also found for the 3 oral DMDs, the results did not reach statistical significance for these smaller subgroups.

also in 111,027 other papers